Peptide therapy for retinal diseases (experimental)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peptide therapy for retinal diseases (experimental), covering 2025-04-25 to 2025-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies [Phase 1, Phase 2]